Cadence Capital Management LLC reduced its position in Tabula Rasa HealthCare Inc (NASDAQ:TRHC) by 63.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 21,680 shares of the company’s stock after selling 38,044 shares during the period. Cadence Capital Management LLC owned approximately 0.12% of Tabula Rasa HealthCare worth $608,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Strs Ohio bought a new position in shares of Tabula Rasa HealthCare during the fourth quarter worth about $137,000. Financial Consulate Inc. bought a new position in shares of Tabula Rasa HealthCare during the third quarter worth about $222,000. Rhumbline Advisers bought a new position in shares of Tabula Rasa HealthCare during the third quarter worth about $253,000. California Public Employees Retirement System bought a new position in shares of Tabula Rasa HealthCare during the third quarter worth about $254,000. Finally, New York State Common Retirement Fund lifted its position in shares of Tabula Rasa HealthCare by 257.0% during the second quarter. New York State Common Retirement Fund now owns 10,000 shares of the company’s stock worth $151,000 after purchasing an additional 7,199 shares during the last quarter. 34.17% of the stock is owned by institutional investors.
Tabula Rasa HealthCare Inc (NASDAQ:TRHC) opened at $35.84 on Wednesday. The company has a quick ratio of 0.66, a current ratio of 0.73 and a debt-to-equity ratio of 0.47. Tabula Rasa HealthCare Inc has a twelve month low of $11.59 and a twelve month high of $38.23. The stock has a market cap of $687.48 and a PE ratio of -210.82.
In other Tabula Rasa HealthCare news, CFO Brian W. Adams bought 5,391 shares of the business’s stock in a transaction on Friday, January 12th. The shares were purchased at an average price of $14.23 per share, with a total value of $76,713.93. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Calvin H. Knowlton sold 8,000 shares of the firm’s stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $34.75, for a total transaction of $278,000.00. The disclosure for this sale can be found here. Insiders sold 1,107,180 shares of company stock worth $28,761,763 in the last three months. 45.80% of the stock is currently owned by corporate insiders.
Several equities analysts have recently commented on TRHC shares. Citigroup started coverage on shares of Tabula Rasa HealthCare in a research report on Thursday, January 4th. They set a “buy” rating on the stock. BidaskClub raised shares of Tabula Rasa HealthCare from a “hold” rating to a “buy” rating in a research report on Thursday, December 21st. Piper Jaffray Companies reaffirmed a “buy” rating and set a $29.00 price target on shares of Tabula Rasa HealthCare in a research report on Tuesday, October 24th. Zacks Investment Research cut shares of Tabula Rasa HealthCare from a “strong-buy” rating to a “hold” rating in a research report on Friday, November 10th. Finally, Wells Fargo & Co increased their price target on shares of Tabula Rasa HealthCare from $21.00 to $27.00 and gave the stock a “market perform” rating in a research report on Thursday, October 19th. Two equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. Tabula Rasa HealthCare presently has a consensus rating of “Buy” and an average target price of $29.78.
ILLEGAL ACTIVITY WARNING: This news story was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright law. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/02/14/cadence-capital-management-llc-has-608000-holdings-in-tabula-rasa-healthcare-inc-trhc.html.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.